It is a healthcare private limited company based in Hyderabad, Telangana, India, established in 2021.
2021 | Hyderabad, Telangana, India | ActiveUtsho Gene Therapy Private Limited, a active private limited company, was established on 06 May 2021 in Hyderabad, Telangana, India. Engaging in human health activities within the healthcare sector, it holds CIN: U85100TG2021PTC151223. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹1.50 M and a paid-up capital of ₹0.10 M.
Its leadership includes Narendra Pindipapanahalli (Director), Prajit Ghosh (Director), Dhara Chirag Mamania (Director). Past directors included Dhara Chirag Mamania, Puneet Ramjilal Bhardwaj. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 303, Fort View Residency Plot 56, Radhanagar Phase 2,Hydershakote, Hyderabad, Telangana, 500008.
U85100TG2021PTC151223
151223
06 May 2021
₹1.50 M
₹0.10 M
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Utsho Gene Therapy Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Narendra Pindipapanahalli | Director | 06 May 2021 | Current |
| Prajit Ghosh | Director | 06 May 2021 | Current |
| Dhara Chirag Mamania | Director | 30 Dec 2022 | Current |
| Puneet Ramjilal Bhardwaj | Director | 14 Aug 2021 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 26 Dec 2022 | Past |
| Pramod Abcsdd | Additional Director | 29 Dec 2022 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Enhance accessibility to Utsho Gene Therapy's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
Unlock access to Utsho Gene Therapy's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Utsho Gene Therapy has a workforce of 0 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Utsho Gene Therapy, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Utsho Gene Therapy's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Utsho Gene Therapy Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
Utsho Gene Therapy Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was recorded as a recent event.
Progress on Dhara Chirag Mamania was appointed as a Director was appointed as a Director on 30 Dec 2022 & has been associated with this company since 2 years 11 months . was documented.
The activity Puneet Ramjilal Bhardwaj was appointed as a Director was appointed as a Director on 14 Aug 2021 & has been associated with this company since 4 years 4 months . was completed.
The activity Narendra Pindipapanahalli was appointed as a Director was appointed as a Director on 06 May 2021 & has been associated with this company since 4 years 7 months . was completed.
Progress on Prajit Ghosh was appointed as a Director was appointed as a Director on 06 May 2021 & has been associated with this company since 4 years 7 months . was documented.
The CIN of Utsho Gene Therapy Private Limited is U85100TG2021PTC151223.
Utsho Gene Therapy Private Limited is headquartered at 303, Fort View Residency Plot 56, Radhanagar Phase 2,Hydershakote, Hyderabad, Telangana, 500008.
Utsho Gene Therapy Private Limited was incorporated on 06 May 2021.
The current directors of Utsho Gene Therapy Private Limited are
The primary industry of Utsho Gene Therapy Private Limited is Healthcare.
Utsho Gene Therapy Private Limited is unlisted.
The authorized capital of Utsho Gene Therapy Private Limited is ₹1.50 M, and the paid-up capital is ₹0.10 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX